Biomarkers for predicting atrial fibrillation: An explorative sub-analysis of the randomised SCREEN-AF trial.
Katharina Schmalstieg-BahrDavid J GladstoneEva HummersJohanna SuerbaumJeffrey S HealeyAntonia ZapfDenise KösterStefanie M WerhahnRolf WachterPublished in: The European journal of general practice (2024)
Natriuretic peptide levels and hsTnI are higher in patients with AF than without and may help select patients for AF screening, but larger trials are needed.
Keyphrases
- atrial fibrillation
- end stage renal disease
- clinical trial
- left atrial
- study protocol
- oral anticoagulants
- catheter ablation
- newly diagnosed
- ejection fraction
- heart failure
- left atrial appendage
- chronic kidney disease
- direct oral anticoagulants
- open label
- peritoneal dialysis
- high throughput
- prognostic factors
- randomized controlled trial
- patient reported